Correlation Between Medpace Holdings and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medpace Holdings and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medpace Holdings and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medpace Holdings and Myriad Genetics, you can compare the effects of market volatilities on Medpace Holdings and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medpace Holdings with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medpace Holdings and Myriad Genetics.

Diversification Opportunities for Medpace Holdings and Myriad Genetics

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Medpace and Myriad is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Medpace Holdings and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Medpace Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medpace Holdings are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Medpace Holdings i.e., Medpace Holdings and Myriad Genetics go up and down completely randomly.

Pair Corralation between Medpace Holdings and Myriad Genetics

Given the investment horizon of 90 days Medpace Holdings is expected to generate 0.85 times more return on investment than Myriad Genetics. However, Medpace Holdings is 1.18 times less risky than Myriad Genetics. It trades about 0.03 of its potential returns per unit of risk. Myriad Genetics is currently generating about 0.0 per unit of risk. If you would invest  30,419  in Medpace Holdings on September 3, 2024 and sell it today you would earn a total of  3,644  from holding Medpace Holdings or generate 11.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medpace Holdings  vs.  Myriad Genetics

 Performance 
       Timeline  
Medpace Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medpace Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Medpace Holdings is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Medpace Holdings and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medpace Holdings and Myriad Genetics

The main advantage of trading using opposite Medpace Holdings and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medpace Holdings position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind Medpace Holdings and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Transaction History
View history of all your transactions and understand their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing